Thanks, Cliff. As we have done in the past, we are reporting both GAAP and non-GAAP numbers. I would like to point out that certain non-GAAP measures adjust for the Midas divestiture. This is similar to past practice. The reconciliations are in our filings and in the appendix of the presentation. Let's turn to Slide 6 and discuss our key sales metrics. As Cliff mentioned, we had our strongest first quarter for overall TCV sales attainment, a 32% increase over Q1 2021. It was also up sequentially 58% versus Q4 2021. Both our Transportation and Commercial segments were up strongly both year-over-year and sequentially. Our Government segment was slightly lower, but its pipeline of late-stage deals remains strong. New business ARR was also up 14% over Q1 2021. In 2022, we launched an enhanced integrated sales model to optimize the balance between near-term and long-term revenue needs and changed our sales compensation models to further incentivize these outcomes with a primary focus on annual contract value. As a reminder, we define ACV as total contract value, or TCV, divided by term. While our ACV reduced 20% as compared to 2021, this impact was driven by the onetime government stimulus volumes in Q1 2021 as well as another onetime volume item for a large client that we no longer record in our sales metrics. Removing these presents a more apples-to-apples view of our ACV. Under this view, ACV grew 12% as compared to Q1 2021. The sales metric trend on the following slide has the same breakout, so you can see the upcoming effect in Q2. The net ARR activity metric, our combined measure of wins, losses, pricing effects and other contractual changes, was positive for the sixth quarter. As a reminder, this trailing 12-month measure does not predict the timing of revenue, but is based on the timing of notification and as such, will fluctuate from quarter-to-quarter. A full definition of this metric is covered in the appendix of our presentation. Turning to Slide 7. Our trends on new business ACV and ARR are encouraging, and our NRR has returned to more normalized levels now we have run off the effect of government stimulus. Our average contract length in the quarter was 3.8 years, which is somewhere near our long-term average. We had another busy first quarter, renewing $936 million of TCV, and with several large clients renewing their agreements and demonstrating their satisfaction and a strong commitment to Conduent as their business process partner. As we have noted before in prior calls, individual quarters can have significant variation due to timing of renewals. Now let's turn to Slide 8 and discuss our Q1 2022 financial results. Adjusted revenue for Q1 2022 was $960 million as compared to $1.01 billion in Q1 2021, down 5% year-over-year and slightly ahead of our internal expectations for the quarter. The year-over-year headwind from the roll-off of government stimulus in the quarter was $27 million. Removing that, the reduction would have been 2.3% year-over-year. Adjusted EBITDA was $107 million for the quarter, up slightly as compared to $105 million in Q1 2021. And the adjusted EBITDA margin of 11.1% was up 70 basis points year-over-year as compared to Q1 2021. Q1 2022 contained a onetime item related to the recovery of approximately $14 million of defense costs as a portion of the settlement with our insurance carriers related to a previously disclosed legal matter. Removing this item, which was not part of how we guided the adjusted EBITDA and margin for the quarter, would have resulted in a 9.7% margin, slightly better than how we guided in our recent 2021 full year earnings call. Let's now turn to Slide 9 and go over the segment results. For Q1 2022, Commercial segment adjusted revenues were flat year-over-year at $512 million as ramp from new business wins begins to more than offset losses from prior years. This is the first quarter that the Commercial segment has not declined year-over-year since spin, and we're pleased with the progress that has been made, while acknowledging there is always more to do as we return the Commercial segment to a sustained path of revenue growth and margin expansion. We anticipate the impact of a long-planned, merger-related revenue reduction from an existing client in Q2 will result in us showing a small year-over-year revenue decline. However, we remain confident on the full year outcome, which I'll talk more about in a minute as we reflect further on full year guidance. Adjusted EBITDA for the Commercial segment in Q1 2022 was $54 million, up 5.9% as compared to Q1 2021, and the adjusted EBITDA margin of 10.5% was up 50 basis points year-over-year, driven by operational efficiency initiatives across the segment. For the Government segment, Q1 2022 revenues were $286 million, down 8.9% compared to Q1 2021. The year-over-year impact of the runoff of government stimulus was $27 million in the quarter. Removing that impact, the underlying base business would have been substantially unchanged year-over-year. Adjusted EBITDA for the Government segment in Q1 2022 was $83 million, down 7.8% year-over-year, reflecting the runoff of government stimulus volumes, partially offset with operational efficiency initiatives. The adjusted EBITDA margin of 29% was up 30 basis points year-over-year. Transportation segment revenues in Q1 2022 were $162 million, down 12% year-over-year. We did expect the Transportation segment to be down in the first quarter, a function of the timing of our strong new business ramp, the majority of which comes on in late Q2, early Q3 time frame, coupled with prior year losses and a onetime revenue item that benefited the prior year. In addition to these items, which were well understood, timing in certain projects in some of our international businesses moved revenue into later quarters in 2022. We do expect these to catch up within the current year. Our full year revenue outlook for Transportation remains unchanged. For the Transportation segment, adjusted EBITDA for the quarter was $17 million, down 43% as compared to Q1 2021. And the adjusted EBITDA margin was 10.5%, down 580 basis points year-over-year. The Q1 2021 adjusted EBITDA margin of 16.3% was the high point in 2021, benefiting as it did from a onetime revenue item with a high fall-through percentage to EBITDA that drove approximately 300 basis points of margin difference with the prior year compare. We anticipate Transportation margins recovering in later quarters, in line with the previous comments on revenue. We don't guide to adjusted EBITDA margin at a segment level. However, in the Transportation segment, our expectation is for full year margins to be at or slightly better than prior year on a full year basis. Let's turn to Slide 10 and discuss the balance sheet and cash flow. Our cash position remains healthy, and we have a strong liquidity position. We ended the quarter with $593 million of cash on the balance sheet. During the quarter, we closed the sale of our Midas suite of solutions, resulting in $321 million of cash consideration subject to customary working capital adjustments, which we expect to finalize in Q2 and do not expect to be material. Overall cash flow was as expected this quarter, with higher CapEx as a percentage of revenue reflecting timing of certain payments which will normalize over the course of the year. On February 11 this year, we repaid the $100 million of debt drawn under our revolving credit facility. And our net leverage ratio decreased to 1.5 turns, which is below what we expect to be our normal range of 2 to 2.5 turns. As Cliff noted in his prepared remarks, we are indexing towards spinning the Transportation segment as a separate public company. As those plans develop, we will clearly provide additional color on how we think about our debt with respect to the 2 entities, their leverage and overall capital structure. In the short term, we believe it is prudent to retain flexibility with cash on hand as we work through those plans. Let's turn to Slide 11 and review our 2022 guidance. We are reconfirming all components of our full year 2022 guidance at this point. We expect adjusted revenues in 2022 to be in the range of $3.825 billion to $3.975 billion. As a reminder, this excludes the impact of the disposition of the Midas business. We have no material changes to our view of the annual segment-level growth trajectories we called out in our full year 2021 earnings update. Our view is that all 3 businesses are on track to meet their full year commitments, with a strong start to our sales year that should feed into our revenue ramp in the second half of the year. However, we do expect overall adjusted revenue in Q2 to be sequentially lower than Q1, specifically in the range of $925 million to $935 million. In Q2 2022, the year-over-year impact of the roll-off of government stimulus is approximately $65 million. There is also an annual component of this sequential trend Q1 to Q2, which relates to the yearly cycle of open enrollment for our health care clients, which starts in Q4 and ends in Q1 the following year. Additionally, the earlier items that I mentioned with the roll off of revenue in the Commercial segment related to a long-planned merger-related activity from an existing client also plays into that rubric. We expect adjusted EBITDA margins to play out similarly to how we talked about them in our recent 2021 full year earnings call, starting the year at or slightly below the guided range and finishing the year at or slightly above the guided range. We still expect to convert approximately 15% of adjusted EBITDA to adjusted free cash flow, inclusive of paying off the remaining portion of the deferred payroll taxes under the CARES Act. Similarly, we are not changing our outlook on CapEx or restructuring charges. That concludes our financial review for Q1 2022, and I'll hand it back to Cliff to talk further about the Transportation announcement. Cliff?